Devil's Claw
- SCIENTIFIC NAMES: Harpagophytum procumbens; Harpagophytum zeyheri
- INDICATIONS: Oral: anorexia, arteriosclerosis, rheumatoid arthritis, GI disorders, fibromyalgia, loss of appetite, headache, fever, high cholesterol, menstrual complaints, liver and gallbladder problems. Topical: rash, ulcers.
- SYNONYM: Pedaliaceae
- CLASS: Analgesic, Anti-inflammatory
- HALF-LIFE: 3–6 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Anesthetics, Antacids, Antiarrhythmics, Anticoagulants, Aspirin, Beta blockers, Histamine H2-antagonists, Hypoglycemics, NSAIDs, Sympathomimetics, Terfenadine
PREGNANCY CATEGORY: N/A
Devil's claw stimulates stomach acid production, and should be avoided by those with stomach or duodenal ulcers. It should not be taken by people with cardiac arrhythmias or other heart problems.
Please login to see the rest of this drug profile
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
OTIC.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations 
- Breast feeding
- Geriatric
- Pediatric